Lancet Correction: Prostate Cancer Radiotherapy Meta-Analysis
The Lancet issued a correction for figure-labeling errors in a 2026 meta-analysis on hormone therapy and radiotherapy for recurrent prostate cancer.
Cardiology Reporter
Sarah Tanaka is an interventional cardiologist at Straub Medical Center in Honolulu. Fellowship-trained in structural heart disease, she reports on cardiovascular research, heart disease treatment advances, and clinical trial outcomes in cardiology for Hawaii Medical Journal.
The Lancet issued a correction for figure-labeling errors in a 2026 meta-analysis on hormone therapy and radiotherapy for recurrent prostate cancer.
New FAERS analysis finds Wegovy carries nearly fivefold higher ischemic optic neuropathy risk vs. Ozempic, raising ocular safety concerns for GLP-1 drugs.